Prostate Cancer Therapeutics Market

Prostate Cancer Therapeutics Market (Therapy- Hormone Therapy (Luteizing Hormone - Releasing Hormone Analogs, Luteinizing Hormone - Releasing Hormone Antagonists, and Anti-androgens), Chemotherapy (Systemic Therapy and Regional Chemotherapy), Biologic Therapy, and Targeted Therapy; Distribution Channel - Hospital Pharmacy, Retail Pharmacy, and Online sales) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2024

  • Rep Id : TMRGL6562
  • Published On : Mar 2018
  • No. of Pages : 171
  • Category : Pharmaceutical

Chapter 1. Preface 
1.1. Report Scope and Market Segmentation 
1.2. Research Highlights

Chapter 2. Assumptions and Research Methodology 
2.1. Assumptions
2.2. Research Methodology

Chapter 3. Executive Summary 
3.1. Global Prostate Cancer Therapeutics Market : Snapshot, 2015
3.2. Global Prostate Cancer Therapeutics Market : Opportunity Map

Chapter 4. Market Overview
4.1. Product Overview
4.2. Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2014–2024 
4.3. Global Prostate Cancer Therapeutics Market Outlook
4.4. Global Prostate Cancer Therapeutics Market : Key Industry Events
4.5. Global Prostate Cancer Therapeutics Market : Porter's Analysis
4.6. Global Prostate Cancer Therapeutics Market : Pipeline Analysis
4.7. Key Product Opportunities

Chapter 5. Market Dynamics
5.1. Drivers and Restraints Snapshot Analysis
5.2. Drivers
       5.2.1. Increasing prevalence of prostate cancer 
       5.2.2. Launch of promising emerging therapies
       5.2.3. Innovation in the development of new drugs and therapeutic biological products
       5.2.4. High growth in hormone-refractory prostate cancer drug due to lesser side effects
5.3. Restrains
       5.3.1. High cost of treatment
       5.3.2. Reluctance toward adoption of premium treatments
5.4. Opportunity Analysis
5.5. Opportunities
       5.5.1. Large undiagnosed patient population
       5.5.2. Rise in funding from both public and private sector in the field of drug development
5.6. Key Trends 
       5.6.1. Increasing application of biotechnology in anticancer drugs development
       5.6.2. New drugs entering the market with higher costs 
       5.6.3. Oral drugs account for a large share of the oncology drugs market

Chapter 6. Prostate Cancer Therapeutics Market Analysis, by Product Type
6.1. Prostate Cancer Therapeutics Market Analysis, by Therapy
6.2. Key Findings
6.3. Introduction
6.4. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Therapy
6.5. Prostate Cancer Therapeutics Market Analysis, by Therapy 
       6.5.1. Hormone Therapy
       6.5.2. Luteinizing Hormone-Releasing Hormone Analogs
       6.5.3. Luteinizing Hormone-Releasing Hormone Antagonists
       6.5.4. Antiandrogens
6.6. Chemotherapy
       6.6.1. Systemic Chemotherapy
       6.6.2. Regional Chemotherapy
6.7. Biologic Therapy
6.8. Targeted Therapy
6.9. Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
6.10. Key Trends

Chapter 7. Prostate Cancer Therapeutics Market Analysis, by Distribution Channel
7.1. Key Findings
7.2. Introduction
7.3. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Distribution Channel
7.4. Prostate Cancer Therapeutics Market Analysis, by Distribution Channel
       7.4.1. Hospital Pharmacy 
       7.4.2. Retail Pharmacy 
       7.4.3. Online Sales 
       7.4.4. Others
7.5. Market Attractiveness Analysis, by Distribution Channel 
7.6. Key Trends

Chapter 8. Prostate Cancer Therapeutics Market Analysis, by Region
8.1. Global Prostate Cancer Therapeutics Market Snapshot, by Country
8.2. Global Prostate Cancer Therapeutics Market Value Share Analysis, by Region
8.3. Prostate Cancer Therapeutics Market Forecast, by Region
8.4. Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2016-2024 

Chapter 9. North America Prostate Cancer Therapeutics Market Analysis
9.1. Key Findings
9.2. North America Prostate Cancer Therapeutics Market Overview
9.3. North America Market Value Share Analysis, by Therapy
9.4. North America Market Forecast, by Therapy
       9.4.1. Hormone Therapy
                9.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
                9.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
                9.4.1.3. Antiandrogens
       9.4.2. Chemotherapy
                9.4.2.1. Systemic Chemotherapy
                9.4.2.2. Regional Chemotherapy
       9.4.3. Biologic Therapy
       9.4.4. Targeted Therapy
9.5. North America Market Value Share Analysis, by Distribution Channel
9.6. North America Market Forecast, by Distribution Channel
       9.6.1. Hospital Pharmacy
       9.6.2. Retail Pharmacy
       9.6.3. Online Sales
       9.6.4. Others
9.7. Market Analysis, by Country
9.8. Market Value Share Analysis, by Country
9.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
       9.9.1. U.S.
       9.9.2. Canada
9.10. Market Attractiveness Analysis
       9.10.1. By Product 
       9.10.2. By Distribution Channel
       9.10.3. By Country
9.11. Market Trends

Chapter 10. Europe Prostate Cancer Therapeutics Market Analysis
10.1. Key Findings
10.2. Europe Prostate Cancer Therapeutics Market Overview
10.3. Europe Market Value Share Analysis, by Therapy
10.4. Europe Market Forecast, by Therapy
       10.4.1. Hormone Therapy
                10.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
                10.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
                10.4.1.3. Antiandrogens
       10.4.2. Chemotherapy
                10.4.2.1. Systemic Chemotherapy
                10.4.2.2. Regional Chemotherapy
       10.4.3. Biologic Therapy
       10.4.4. Targeted Therapy
10.5. Europe Market Value Share Analysis, by Distribution Channel
10.6. Europe Market Forecast, by Distribution Channel
       10.6.1. Hospital Pharmacy
       10.6.2. Retail Pharmacy
       10.6.3. Online Sales
       10.6.4. Others
10.7. Market Analysis, by Country
10.8. Market Value Share Analysis, by Country
10.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
       10.9.1. U.K.
       10.9.2. Germany
       10.9.3. Italy
       10.9.4. France
       10.9.5. Spain
       10.9.6. Russia
       10.9.7. Rest of Europe
10.10. Market Attractiveness Analysis
       10.10.1. By Product 
       10.10.2. By Distribution Channel
       10.10.3. By Country
10.11. Market Trends

Chapter 11. Asia Pacific Prostate Cancer Therapeutics Market Analysis
11.1. Key Findings
11.2. Asia Pacific Prostate Cancer Therapeutics Market Overview
11.3. Asia Pacific Market Value Share Analysis, by Therapy
11.4. Asia Pacific Market Forecast, by Therapy
       11.4.1. Hormone Therapy
                11.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
                11.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
                11.4.1.3. Antiandrogens
       11.4.2. Chemotherapy
11.4.2.1. Systemic Chemotherapy
11.4.2.2. Regional Chemotherapy
       11.4.3. Biologic Therapy
       11.4.4. Targeted Therapy
11.5. Asia Pacific Market Value Share Analysis, by Distribution Channel
11.6. Asia Pacific Market Forecast, by Distribution Channel
       11.6.1. Hospital Pharmacy
       11.6.2. Retail Pharmacy
       11.6.3. Online Sales
       11.6.4. Others
11.7. Market Analysis, by Country
11.8. Market Value Share Analysis, by Country
11.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
       11.9.1. China
       11.9.2. Japan
       11.9.3. India
       11.9.4. Australia & New Zealand
       11.9.5. Rest of Asia Pacific
11.10. Market Attractiveness Analysis
       11.10.1. By Product 
       11.10.2. By Distribution Channel
       11.10.3. By Country
11.11. Market Trends

Chapter 12. Latin America Prostate Cancer Therapeutics Market Analysis
12.1. Key Findings
12.2. Latin America Prostate Cancer Therapeutics Market Overview
12.3. Latin America Market Value Share Analysis, by Therapy
12.4. Latin America Market Forecast, by Therapy
       12.4.1. Hormone Therapy
                12.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
                12.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
                12.4.1.3. Antiandrogens       
       12.4.2. Chemotherapy
                12.4.2.1. Systemic Chemotherapy
                12.4.2.2. Regional Chemotherapy
       12.4.3. Biologic Therapy
       12.4.4. Targeted Therapy
12.5. Latin America Market Value Share Analysis, by Distribution Channel
12.6. Latin America Market Forecast, by Distribution Channel
       12.6.1. Hospital Pharmacy
       12.6.2. Retail Pharmacy
       12.6.3. Online Sales
       12.6.4. Others
12.7. Market Analysis, by Country
12.8. Market Value Share Analysis, by Country
12.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
       12.9.1. Brazil
       12.9.2. Mexico
       12.9.3. Rest of Latin America
12.10. Market Attractiveness Analysis
       12.10.1. By Product 
       12.10.2. By Distribution Channel
       12.10.3. By Country
12.11. Market Trends

Chapter 13. Middle East & Africa Prostate Cancer Therapeutics Market Analysis
13.1. Key Findings
13.2. Middle East & Africa Prostate Cancer Therapeutics Market Overview
13.3. Middle East & Africa Market Value Share Analysis, by Therapy
13.4. Middle East & Africa Market Forecast, by Therapy
       13.4.1. Hormone Therapy
                13.4.1.1. Luteinizing Hormone-Releasing Hormone Analogs
                13.4.1.2. Luteinizing Hormone-Releasing Hormone Antagonists
                13.4.1.3. Antiandrogens
       13.4.2. Chemotherapy
                13.4.2.1. Systemic Chemotherapy
                13.4.2.2. Regional Chemotherapy
       13.4.3. Biologic Therapy
       13.4.4. Targeted Therapy
13.5. Middle East & Africa Market Value Share Analysis, by Distribution Channel
13.6. Middle East & Africa Market Forecast, by Distribution Channel
       13.6.1. Hospital Pharmacy
       13.6.2. Retail Pharmacy
       13.6.3. Online Sales 
       13.6.4. Others
13.7. Market Analysis, by Country
13.8. Market Value Share Analysis, by Country
13.9. Market Size (US$ Mn) Forecast, by Country, 2016–2024
       13.9.1. Brazil
       13.9.2. Mexico
       13.9.3. Rest of Latin America
13.10. Market Attractiveness Analysis
       13.10.1. By Product 
       13.10.2. By Distribution Channel
       13.10.3. By Country
13.11. Market Trends

Chapter 14. Company Profiles
14.1. Prostate Cancer Therapeutics Market Share Analysis, by Company, 2016 (Estimated)
14.2. Competition Matrix
14.3. Company Profiles
       14.3.1. Amgen, Inc.
                14.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.1.2. Financial Overview
                14.3.1.3. Product Portfolio
                14.3.1.4. SWOT Analysis
                14.3.1.5. Strategic Overview
       14.3.2. Johnson & Johnson (Janssen Biotech, Inc.)
                14.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.2.2. Financial Overview
                14.3.2.3. Product Portfolio
                14.3.2.4. SWOT Analysis
                14.3.2.5. Strategic Overview
       14.3.3. Pfizer, Inc. 
                14.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.3.2. Financial Overview
                14.3.3.3. Product Portfolio
                14.3.3.4. SWOT Analysis
                14.3.3.5. Strategic Overview
       14.3.4. AstraZeneca
                14.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.4.2. Financial Overview
                14.3.4.3. Product Portfolio
                14.3.4.4. SWOT Analysis
                14.3.4.5. Strategic Overview
       14.3.5. AbbVie, Inc.
                14.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.5.2. Financial Overview
                14.3.5.3. Product Portfolio
                14.3.5.4. SWOT Analysis
                14.3.5.5. Strategic Overview
       14.3.6. Bayer AG 
                14.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.6.2. Financial Overview
                14.3.6.3. Product Portfolio
                14.3.6.4. SWOT Analysis
                14.3.6.5. Strategic Overview
       14.3.7. Ipsen Group
                14.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.7.2. Financial Overview
                14.3.7.3. Product Portfolio
                14.3.7.4. SWOT Analysis
                14.3.7.5. Strategic Overview
       14.3.8. Sanofi
                14.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.8.2. Financial Overview
                14.3.8.3. Product Portfolio
                14.3.8.4. SWOT Analysis
                14.3.8.5. Strategic Overview
       14.3.9. Endo Pharmaceuticals, Inc. 
                14.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
                14.3.9.2. Financial Overview
                14.3.9.3. Product Portfolio
                14.3.9.4. SWOT Analysis
                14.3.9.5. Strategic Overview
       14.3.10. Dendreon Corporation (Sanpower Group Co. Ltd.) 
                14.3.10.1. Company Overview (HQ, Business Segments,)
                14.3.10.2. Product Portfolio
                14.3.10.3. SWOT Analysis
                14.3.10.4. Strategic Overview

List of Tables

Table 1: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 2: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 3: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 4: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 5: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Region, 2014–2024
Table 6: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 7: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 8: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 9: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 10: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 11: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 12: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 13: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 14: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 15: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 16: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 17: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 18: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 19: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 20: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 21: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 22: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 23: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy, 2014–2024
Table 24: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 25: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024
Table 26: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Therapy, 2014–2024
Table 27: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Hormone Therapy, 2014–2024
Table 28: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Chemotherapy (Therapy), 2014–2024
Table 29: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Distribution Channel, 2014–2024
Table 30: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, by Country, 2014–2024

List of Figures

Figure 1: Global Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast, 2014–2024
Figure 2: Global Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 3: Global Hormone Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 4: Global Chemotherapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 5: Global Biologic Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 6: Global Targeted Therapy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 7: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 8: Global Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 9: Global Hospital Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 10: Global Retail Pharmacy Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 11: Global Online Sales Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 12: Global Others Market Revenue (US$ Mn) and Y-o-Y Growth (%), 2014–2024
Figure 13: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 14: Global Prostate Cancer Therapeutics Market Value Share, by Region, 2016 and 2024
Figure 15: Global Prostate Cancer Therapeutics Market Attractiveness Analysis, by Region, 2016–2024
Figure 16: North America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 17: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016–2024
Figure 18: North America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 19: North America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 20: North America Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 21: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 22: North America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 23: Europe Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 24: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016–2024
Figure 25: Europe Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 26: Europe Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 27: Europe Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 28: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016–2024
Figure 29: Europe Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016–2024
Figure 30: Asia Pacific Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 31: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016-2024
Figure 32: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 33: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 34: Asia Pacific Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 35: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
Figure 36: Asia Pacific Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016-2024
Figure 37: Latin America Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 38: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016-2024
Figure 39: Latin America Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 40: Latin America Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 41: Latin America Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 42: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
Figure 43: Latin America Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016-2024
Figure 44: Middle East & Africa Prostate Cancer Therapeutics Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2016–2024
Figure 45: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Country, 2016-2024
Figure 46: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Therapy, 2016 and 2024
Figure 47: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Distribution Channel, 2016 and 2024
Figure 48: Middle East & Africa Prostate Cancer Therapeutics Market Value Share, by Country, 2016 and 2024
Figure 49: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Therapy, 2016-2024
Figure 50: Middle East & Africa Prostate Cancer Therapeutics Market Attractiveness Analysis, by Distribution Channel, 2016-2024
Figure 51: Global Prostate Cancer Therapeutics Market Share Analysis, by Company, 2016 (Estimated)

.